Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
Recruiting · NCT06110130 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD | Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 4 | 2026-08-21 | NCT06110130 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boehringer Ingelheim | 158 |
| Washington D.C. Veterans Affairs Medical Center | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Washington DC Veterans Affairs Medical Center (688) | Washington D.C. | United States | 2 |